Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 75 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Disease-Free Survival  [Clear All Filters]
2018
Arzoglou, V., Tsitlakidis A., Foroglou N., Polyzoidis K., Makri S., & Patsalas I. (2018).  Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma?. Br J Neurosurg. 32(6), 614-618.
Christodoulou, C., Oikonomopoulos G., Koliou G. Angeliki, Kostopoulos I., Kotoula V., Bobos M., et al. (2018).  Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.. Cancer Genomics Proteomics. 15(6), 461-471.
Fountzilas, G., Psyrri A., Giannoulatou E., Tikas I., Manousou K., Rontogianni D., et al. (2018).  Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.. Int J Cancer. 142(1), 66-80.
Katodritou, E., Kyrtsonis M-C., Delimpasi S., Kyriakou D., Symeonidis A., Spanoudakis E., et al. (2018).  Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.. Ann Hematol. 97(9), 1671-1682.
Katodritou, E., Terpos E., Delimpasi S., Kotsopoulou M., Michalis E., Vadikolia C., et al. (2018).  Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.. Blood Cancer J. 8(3), 31.
2017
Li, Y., Esmail A., Donas K. P., Pitoulias G., Torsello G., Bisdas T., et al. (2017).  Antegrade vs Crossover Femoral Artery Access in the Endovascular Treatment of Isolated Below-the-Knee Lesions in Patients With Critical Limb Ischemia.. J Endovasc Ther. 24(3), 331-336.
Psyrri, A., Kalogeras K. T., Wirtz R. M., Kouvatseas G., Karayannopoulou G., Goussia A., et al. (2017).  Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.. J Transl Med. 15(1), 30.
Kostopoulos, I. V., Paterakis G., Pavlidis D., Kastritis E., Terpos E., Tsitsilonis O. E., et al. (2017).  Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis.. Blood Cancer J. 7(8), e597.
Giannopoulos, G., Kossyvakis C., Angelidis C., Panagopoulou V., Tsiachris D., Vrachatis D. A., et al. (2017).  Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence.. Europace. 19(12), 1967-1972.
Neofytou, K., Giakoustidis A., Neves M. Costa, Morrison D., Giakoustidis D., Khan A. Z., et al. (2017).  Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.. Langenbecks Arch Surg. 402(4), 599-605.
Muraro, P. A., Pasquini M., Atkins H. L., Bowen J. D., Farge D., Fassas A., et al. (2017).  Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.. JAMA Neurol. 74(4), 459-469.
Levva, S., Kotoula V., Kostopoulos I., Manousou K., Papadimitriou C., Papadopoulou K., et al. (2017).  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.. Cancer Genomics Proteomics. 14(3), 181-195.
Paraskevaidis, S., Konstantinou D., Kolettas V., Stavropoulos G., Koutsakis A., Nikolaidou C., et al. (2017).  The role of catheter ablation in the management of patients with implantable cardioverter defibrillators presenting with electrical storm.. Hellenic J Cardiol. 58(1), 51-56.
2016
Kotoula, V., Karavasilis V., Zagouri F., Kouvatseas G., Giannoulatou E., Gogas H., et al. (2016).  Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.. Breast Cancer Res Treat. 158(2), 307-21.
Matikas, A., Kentepozidis Ν., Ardavanis A., Vaslamatzis M., Polyzos A., Emmanouilides C., et al. (2016).  Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).. Cancer Chemother Pharmacol. 78(2), 369-76.
Cohen, S. A., Wu C., Yu M., Gourgioti G., Wirtz R., Raptou G., et al. (2016).  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clin Colorectal Cancer. 15(2), 164-9.
Pectasides, D., Kotoula V., Papaxoinis G., Alexopoulou Z., Dervenis C., Samantas E., et al. (2016).  Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer.. Anticancer Res. 36(12), 6347-6356.
Pampena, R., Palmieri T., Kyrgidis A., Ramundo D., Iotti C., Lallas A., et al. (2016).  Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): Comparison between 2 different schedules.. J Am Acad Dermatol. 74(2), 341-7.
Silveira, D., Pitoulias G., Torsello G., & Donas K. P. (2016).  Outcomes of total endovascular treatment of juxtarenal aortic aneurysms in octogenarians.. J Vasc Surg. 63(4), 909-14.
Fountzilas, G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., et al. (2016).  TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.. Oncotarget. 7(22), 32731-53.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.